RNAZ
NASDAQ · Biotechnology
Transcode Therapeutics Inc
$6.60
-0.19 (-2.78%)
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+200.3% upside
Low Target
$14.35
Average Target
$19.82
High Target
$27.60
Current Price
$6.60
Current
$6.60
$6.60
Target
$19.82
$19.82
$14.35
$19.82 avg
$27.60
Scenario Analysis
Bear Case
$14.35
117.4%
Low target
Base Case
$19.82
+200.3%
Avg target
Bull Case
$27.60
+318.2%
High target
Risk/Reward
2.7x
Favorable
Price in Context
52-Week High
$20.99
-68.6% from high
52-Week Low
$6.08
+8.5% from low
Target vs 52W High
$19.82
-5.6% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 40 | 75% | $257.58 | +22.4% |
| AMGN | Hold | 44 | 48% | $190.87 | -41.5% |
| GILD | Strong Buy | 39 | 79% | $362.68 | +179.9% |
| VRTX | Strong Buy | 39 | 79% | $438.34 | +0.3% |
| REGN | Strong Buy | 38 | 79% | $76.80 | -89.0% |
| ALNY | Strong Buy | 36 | 75% | $102.31 | -64.3% |
| RVMD | Strong Buy | 27 | 96% | $114.11 | -21.7% |
| BIIB | Buy | 43 | 56% | $91.45 | -52.6% |